Dataset from the comparative evaluation of the STANDARD M10 point-of-care analyzer versus the NeuMoDx assay for the molecular diagnosis of SARS-CoV-2

The STANDARD M10 is a novel cartridge-based real time RT-PCR point of care platform that provides significant advantages regarding SARS-CoV-2 detection including fast turnaround times and no need for specialized personnel and facilities. This assay was recently evaluated in our hospital as a rapid a...

Full description

Bibliographic Details
Main Authors: Georgios Meletis, Areti Tychala, Ioanna Gkeka, Efthymia Protonotariou, Lemonia Skoura
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Data in Brief
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352340922008952
_version_ 1811311005635969024
author Georgios Meletis
Areti Tychala
Ioanna Gkeka
Efthymia Protonotariou
Lemonia Skoura
author_facet Georgios Meletis
Areti Tychala
Ioanna Gkeka
Efthymia Protonotariou
Lemonia Skoura
author_sort Georgios Meletis
collection DOAJ
description The STANDARD M10 is a novel cartridge-based real time RT-PCR point of care platform that provides significant advantages regarding SARS-CoV-2 detection including fast turnaround times and no need for specialized personnel and facilities. This assay was recently evaluated in our hospital as a rapid alternative to the already present NeuMoDx assay that is used in everyday practice. For this purpose, 30 nasopharyngeal samples by patients admitted to our hospital were used, regardless of clinical suspicion of COVID-19. In our evaluation, the sensitivity of STANDARD M10 was 95%, the specificity was 100%, the positive predictive value was 100%, the negative predictive value was 90% and the kappa coefficient of agreement was 0.927 (p < 0.001).
first_indexed 2024-04-13T10:10:14Z
format Article
id doaj.art-e289bf636d484707a13cbba6d98493e8
institution Directory Open Access Journal
issn 2352-3409
language English
last_indexed 2024-04-13T10:10:14Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series Data in Brief
spelling doaj.art-e289bf636d484707a13cbba6d98493e82022-12-22T02:50:57ZengElsevierData in Brief2352-34092022-12-0145108690Dataset from the comparative evaluation of the STANDARD M10 point-of-care analyzer versus the NeuMoDx assay for the molecular diagnosis of SARS-CoV-2Georgios Meletis0Areti Tychala1Ioanna Gkeka2Efthymia Protonotariou3Lemonia Skoura4Corresponding author at: AHEPA University Hospital, S. Kiriakidi str. 1, 54636, Thessaloniki, Greece.; Department of Microbiology, AHEPA University Hospital, S. Kiriakidi str. 1, 54636, Thessaloniki, GreeceDepartment of Microbiology, AHEPA University Hospital, S. Kiriakidi str. 1, 54636, Thessaloniki, GreeceDepartment of Microbiology, AHEPA University Hospital, S. Kiriakidi str. 1, 54636, Thessaloniki, GreeceDepartment of Microbiology, AHEPA University Hospital, S. Kiriakidi str. 1, 54636, Thessaloniki, GreeceDepartment of Microbiology, AHEPA University Hospital, S. Kiriakidi str. 1, 54636, Thessaloniki, GreeceThe STANDARD M10 is a novel cartridge-based real time RT-PCR point of care platform that provides significant advantages regarding SARS-CoV-2 detection including fast turnaround times and no need for specialized personnel and facilities. This assay was recently evaluated in our hospital as a rapid alternative to the already present NeuMoDx assay that is used in everyday practice. For this purpose, 30 nasopharyngeal samples by patients admitted to our hospital were used, regardless of clinical suspicion of COVID-19. In our evaluation, the sensitivity of STANDARD M10 was 95%, the specificity was 100%, the positive predictive value was 100%, the negative predictive value was 90% and the kappa coefficient of agreement was 0.927 (p < 0.001).http://www.sciencedirect.com/science/article/pii/S2352340922008952COVID-19Rapid testingPOCSARS-CoV-2 molecular detection
spellingShingle Georgios Meletis
Areti Tychala
Ioanna Gkeka
Efthymia Protonotariou
Lemonia Skoura
Dataset from the comparative evaluation of the STANDARD M10 point-of-care analyzer versus the NeuMoDx assay for the molecular diagnosis of SARS-CoV-2
Data in Brief
COVID-19
Rapid testing
POC
SARS-CoV-2 molecular detection
title Dataset from the comparative evaluation of the STANDARD M10 point-of-care analyzer versus the NeuMoDx assay for the molecular diagnosis of SARS-CoV-2
title_full Dataset from the comparative evaluation of the STANDARD M10 point-of-care analyzer versus the NeuMoDx assay for the molecular diagnosis of SARS-CoV-2
title_fullStr Dataset from the comparative evaluation of the STANDARD M10 point-of-care analyzer versus the NeuMoDx assay for the molecular diagnosis of SARS-CoV-2
title_full_unstemmed Dataset from the comparative evaluation of the STANDARD M10 point-of-care analyzer versus the NeuMoDx assay for the molecular diagnosis of SARS-CoV-2
title_short Dataset from the comparative evaluation of the STANDARD M10 point-of-care analyzer versus the NeuMoDx assay for the molecular diagnosis of SARS-CoV-2
title_sort dataset from the comparative evaluation of the standard m10 point of care analyzer versus the neumodx assay for the molecular diagnosis of sars cov 2
topic COVID-19
Rapid testing
POC
SARS-CoV-2 molecular detection
url http://www.sciencedirect.com/science/article/pii/S2352340922008952
work_keys_str_mv AT georgiosmeletis datasetfromthecomparativeevaluationofthestandardm10pointofcareanalyzerversustheneumodxassayforthemoleculardiagnosisofsarscov2
AT aretitychala datasetfromthecomparativeevaluationofthestandardm10pointofcareanalyzerversustheneumodxassayforthemoleculardiagnosisofsarscov2
AT ioannagkeka datasetfromthecomparativeevaluationofthestandardm10pointofcareanalyzerversustheneumodxassayforthemoleculardiagnosisofsarscov2
AT efthymiaprotonotariou datasetfromthecomparativeevaluationofthestandardm10pointofcareanalyzerversustheneumodxassayforthemoleculardiagnosisofsarscov2
AT lemoniaskoura datasetfromthecomparativeevaluationofthestandardm10pointofcareanalyzerversustheneumodxassayforthemoleculardiagnosisofsarscov2